JOURNAL ARTICLE

Near-Infrared Light-Triggered Drug-Delivery Vehicle for Mitochondria-Targeted Chemo-Photothermal Therapy

Enguo JuZhenhua LiZhen LiuJinsong RenXiaogang Qu

Year: 2014 Journal:   ACS Applied Materials & Interfaces Vol: 6 (6)Pages: 4364-4370   Publisher: American Chemical Society

Abstract

A novel drug-delivery vehicle for mitochondria-targeted chemo-photothermal therapy was demonstrated. A cytochrome c-specific binding aptamer was employed to make the mesoporous silica-encapsulated gold nanorods efficiently accumulate in the mitochondria of cancer cells. This nanocarrier can load various hydrophobic therapeutic agents acting on mitochondria to enhance the therapeutic efficiency and simultaneously depress the toxic side effects. In addition, near-IR treatment could induce cytochrome c release and initiation of the mitochondrial pathway of apoptosis. Importantly, this multifunctional platform could integrate targeting, light-triggered release, and chemo-photothermal therapy into one system. We hope that such a system could open the door to the fabrication of a multifunctional mitochondria-targeted drug-delivery vehicle for cancer therapy.

Keywords:
Photothermal therapy Nanocarriers Mesoporous silica Materials science Drug delivery Mitochondrion Cytochrome c Photothermal effect Nanotechnology HeLa Targeted drug delivery Apoptosis Cancer therapy Cancer cell Drug Biophysics Nanorod Cancer Pharmacology Mesoporous material Cell biology Chemistry In vitro Biochemistry Biology

Metrics

102
Cited By
7.23
FWCI (Field Weighted Citation Impact)
36
Refs
0.98
Citation Normalized Percentile
Is in top 1%
Is in top 10%

Citation History

Topics

Nanoplatforms for cancer theranostics
Physical Sciences →  Engineering →  Biomedical Engineering
Advanced Nanomaterials in Catalysis
Physical Sciences →  Materials Science →  Materials Chemistry
Advanced biosensing and bioanalysis techniques
Life Sciences →  Biochemistry, Genetics and Molecular Biology →  Molecular Biology

Related Documents

© 2026 ScienceGate Book Chapters — All rights reserved.